LUNG CARCINOMA

This early-stage study aims to find safe doses of a three-drug combination for treating advanced solid tumors in patients who also have kidney or liver problems. Researchers are testing a new drug called veliparib, given with two standard chemotherapy drugs, to see how the body p…

This study is testing whether a combination of tools can help cancer survivors living in rural areas better manage their health after treatment ends. Participants create their own survivorship care plan and some receive a phone-based education session. The goal is to see if this …

This study tests whether a centralized care coordination system can help more people complete their recommended follow-up appointments after lung cancer screening. It involves over 6,700 current or former heavy smokers at community health centers. The program tracks patients, sen…

This large national trial is testing whether choosing cancer drugs based on the specific genetic changes found in a patient's tumor is more effective than standard approaches. It is for adults with advanced solid tumors, lymphoma, or multiple myeloma that have progressed after at…

This study is testing whether using suction during a lung biopsy procedure helps doctors get better tissue samples for cancer testing. Researchers are comparing samples taken with and without suction in 50 patients with suspected lung cancer that may have spread to lymph nodes. T…

This early-phase study is testing a new radioactive tracer called 18F-αvβ6-BP to see if it can help doctors better locate cancers in the body using PET scans. The study involves 27 patients with breast, colorectal, lung, or pancreatic cancer. Researchers will inject the tracer an…

This study is testing whether a program of virtual exercise classes and group counseling is practical and can improve health in people at high risk for lung cancer. Researchers want to see if this program changes the mix of bacteria in the gut and reduces body-wide inflammation, …

This study is testing whether a drug called canakinumab can help prevent lung cancer in former heavy smokers. Researchers are giving the drug to 41 participants to see if it reduces inflammation in the lungs, which is linked to cancer development. The main goal is to see if block…

This study is testing if a widely used, safe diabetes medication called metformin can lower the chance of developing lung cancer. It involves 50 overweight former and current smokers who are at high risk for the disease. Researchers want to see if taking metformin daily for six m…

This study is testing whether a yoga program can help cancer patients and their partners feel better during radiation treatment. It will enroll 600 couples where one person has lung, head and neck, or esophageal cancer. Researchers want to see if doing yoga together improves phys…

This study is testing a web-based education tool called HOPE-Genomics. It aims to help cancer patients better understand their personal genetic test results and general cancer genomics. Researchers are comparing the tool's effectiveness against standard education methods to see i…

This study is looking at what happens when older smokers at high risk for lung cancer switch from regular cigarettes to e-cigarettes. Researchers are measuring changes in smoking habits and certain health markers in the blood over 26 weeks. The goal is to gather information to he…

This study aimed to understand how community cancer clinics test for biomarkers—specific genetic changes in tumors—to help guide treatment decisions for common cancers like breast, lung, and colorectal. It planned to survey pathology labs to see what tests they run, how quickly t…